SEATTLE, May 26, 2021, (MEDGADGET) — Overview:
Human immunoglobulin can provide passive immunity as well as immunomodulatory and anti-inflammatory effect, resulting in better treatment and prognosis of severe infections, such as COVID-19. It also helps people with immune thrombocytopenic purpura to increase their platelets and prevent infections in individuals with B-cell chronic lymphocytic leukaemia. Moreover, human immunoglobulin is being widely researched to develop a safe and effective treatment of COVID-19.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/3790
In 2020, the global human immunoglobulin for intravenous injection (COVID-19) market is valued at US$ 43,205.8 million and is expected to exhibit a CAGR of 12.7% during the forecast period (2020-2027).
Drivers:
Increasing focus towards product approvals is expected to drive growth of the global human immunoglobulin (pH4) for intravenous injection (COVID-19) market over the forecast period. For instance, CSL Behring, a plasma-derived and recombinant therapeutics manufacturer, received approval from Japan’s Ministry of Health, Labour, and Welfare in March 2019 for Privigen, an intravenous immunoglobulin (IVIG), for the treatment of patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Moreover, increase in research and development to develop safe and effective COVID-19 treatment is expected boost growth of the global human immunoglobulin (pH4) for intravenous injection (COVID-19) market. For instance, in March 2020, Takeda Pharmaceutical initiated the development of TAK-888, an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) to treat COVID-19 patients.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/3790
Competitive Section:
Key players active in the global human immunoglobulin (pH4) for intravenous injection (COVID-19) market are Baxter International Inc., Takeda Pharmaceutical Company Limited, Bayer AG, CSL Behring, S.A., Grifols, Octapharma AG, , Hualan Biological Engineering Inc., Shanghai RAAS Blood Products Co., Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., China Biologic Products, Inc., Sinopharm Group Co., Ltd., ADMA Biologics, Inc., and Boya Bio-Pharmaceutical Group Co., Ltd.
Read Press Release: https://www.coherentmarketinsights.com/press-release/human-immunoglobulin-ph4-for-intravenous-injection-market-3057
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Disease Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Industry Trend
- Merger and Acquisitions
- New Disease Indication Approvals/Launch
- Promotion and Marketing Initiatives
- PEST Analysis
- Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market, By Type, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- IgG
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- IgA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- IgM
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market, By Disease Indication, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- COVID-19
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Primary Immunodeficiency Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Immune-mediated Thrombocytopenia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Kawasaki Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- B Chronic lymphocytic Leukemia(B-CLL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market, By Region, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2027
- North America
- Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Section
- References
- Research Methodology
- About Us and Sales Contact
Other Exclusive Reports:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837